Skip to main content
. 2023 Dec 12;11(12):1841. doi: 10.3390/vaccines11121841

Figure 3.

Figure 3

Percentage distribution of serogroups in cases of meningococcal disease by year in Argentina (A), Brazil (B), Chile (C), and Uruguay (D), 2010–2021. The year of introduction of meningococcal conjugated vaccine (MCV) into National Immunization Programs at determined ages is pointed out for each country; m = months of age, and y = years of age. “Others” include non-BCWY serogroups, non-serogroupable, and unknowns. No cases due to MenA were reported in Argentina, Brazil, Chile, or Uruguay during the period.